Session Details

[29-11-am]Organ systems, Blood and hematopoietic system, Skeletal muscles and smooth muscles, Bones and joints, Skins and sensory organs, Endocrine and metabolic systems

Sat. Mar 29, 2025 8:30 AM - 9:54 AM JST
Sat. Mar 29, 2025 11:30 PM - 12:54 AM UTC
Room 11 (Fukuoka International Congress Center: 413 [4F])
Chair: Yukihiko Sugimoto, Tatsuya Morimoto

[29-11-am01S]The mechanism of renoprotective action of SMTP-44D against diabetic nephropathy

○Taiki Awane1,2, Keita Shibata1,2, Keiji Hasumi3,4, Koji Nobe1,2 (1. Showa Univ. Grad. Sch. Pharm., 2. Showa Univ. Pharmacol. Res. Cet., 3. Tokyo Univ. Agric. & Technol. Grad. Sch. Agric., 4. TMS Co., Ltd.)

[29-11-am02S]Peptidylarginine deiminase 2 contributes to TNBS-induced murine colitis via extracellular traps-independent manner

○Yuka Makino1, Takuma Higashiura1, Usa Yamamoto1, Michiko Saito2, Hiroyuki Yasuda1, Syusaku Hayashi1, Shinichi Kato1 (1. Kyoto Pharmaceutical University, 2. Bioscience Research Center, Kyoto Pharmaceutical University)

[29-11-am03S]Hepatoprotective effects of 3-amino-4-hydroxy benzonic acid (AHBA) thorough the suppressing of NAS and fibrosis against NASH.

○Seitarou Aoki1,3, Keita Shibata2,3, Tomoaki Yamaguchi2, Keiji Hasumi4, Koji Nobe2,3 (1. Showa Univ. Sch. Pharm., 2. Showa Univ. Grad. Sch. Pharm., 3. Showa Univ. Pharmacol. Res. Cet., 4. Tokyo Univ. Agric. & Technol. Grad. Sch. Agric.)

[29-11-am04]Novel Pharmacological Effects of Multifunctional Niosome-Forming Diacylglycerol PEG Adducts on Epidermal Barrier Function and Moisture Retention

○Tatsuro Miyoshi1,2, Brian C. Keller1, Takashi Ashino2, Satoshi Numazawa2 (1. Beverly Glen Laboratories, Inc., 2. Department of Toxicology, Showa University Graduate School of Pharmacy)

[29-11-am05S]Peptidylarginine deiminase 4 contributes to pathogenesis of TNBS-induced colitis in mice.

○Asuka Maruyama1, Miru Ihara1, Mizuki Murai1, Koki Okuzono1, Michiko Saito2, Hiroyuki Yasuda1, Shusaku Hayashi1, Shinichi Kato1 (1. Kyoto Pharmaceutical University , 2. Bioscience Research Center, Kyoto Pharmaceutical University)

[29-11-am06S]Neonatal hypoglycemia caused by ritodrine is due to inhibition of neonatal hepatic gluconeogenesis

○Mayu Kajino1, Arimi Fujita1,2, Ayuka Itaya3, Tsutomu Shimada1,2,3, Yuka Inaba4, Hiroshi Inoue4, Yoshimichi Sai1,2 (1. Grad. Sch. Med. Sci., Kanazawa Univ., 2. Hosp. Pharm., Kanazawa Univ., 3. Fac. Pharm., Kanazawa Univ., 4. Inst. Front. Sci. Initiative., Kanazawa Univ.)

[29-11-am07S]Development of non-invasive diagnostic method for MASLD

○Mayuki Okabe1, Momoka Yamaguchi1,2, Akira Ooka1,2, Genki Ozawa3, Yukiko Kaneko1,2, Kei Suzuki3, Takayoshi Hisada3, Jun Mochizuki3, Tomohisa Ishikawa1,2 (1. Dept. Pharmacol., Sch. Pharm. Sci., Univ.Shizuoka, 2. Grad. Sch. Pharm. Sci., Univ. of Shizuoka, 3. TechnoSuruga Lab. Co., Ltd.)